Navigation Links
World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at

London, UK (PRWEB) July 11, 2014

Microbiology testing is a highly dynamic and rapidly growing segment of the in-vitro diagnostics industry, which is expected to pose the biggest challenge to suppliers in the next ten years. The sector owes its growth to the ongoing spread of AIDS – still the key threat to people’s health worldwide and a major factor leading to the upsurge of opportunistic infections, novel molecular diagnostic technologies, threat of bio-terrorism, and a broader availability of immunosuppressants, among others.

Market maturity, fierce competition, cost containment solutions, technological edge and limitations, patent rights protection, regulatory restrictions, and decentralised testing market challenges, among others, fall within the major factors limiting the sector’s growth.

Comprehensive research report “Emerging Opportunities in the Global Virology and Bacteriology Testing Market” worked out by Venture Planning Group (VPG) is now available at

Report Details:

Title: Emerging Opportunities in the Global Virology and Bacteriology Testing Market
Published: June, 2014
Pages: 1900
Price: US$ 32,500.00

The research report provides a strategic analysis of key business opportunities in the infectious disease testing market across the 7 key countries over the forthcoming years. The report keeps track of the prevalent trends in national markets; reviews assays, current and emerging; analyses potential applications of novel diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimated figures by method (serology/immunodiagnostics, molecular, culture/microscopy); presents detailed profiles of the leading players and potential market entrants. Alternative business expansion strategies for suppliers are at hand in the study, too.

Report Scope:

  •     Global market overview, including the estimated number of laboratories performing infectious disease tests (by country), test volume and sales projections for major diagnostic assays for infectious diseases (by country).
  •     Shrewd look at the opportunities emerging plus strategic recommendations.
  •     Thorough examination of different infectious diseases.
  •     Comprehensive country wide market analyses for Germany, France, Italy, the UK, Spain, Japan, and the US.
  •     Detailed market segmentation, featuring sales and market shares of leading suppliers by individual country and test; and also sales and volume forecasts for more than 100 infectious disease assays by individual test, country and market segment.
  •     Analysis of existing and emerging products, comprising exhaustive examination of over 100 major diseases; as well as a detailed overview of major analysers utilised for infectious disease testing.
  •     Comprehensive assessment of technologies (molecular diagnostic, monoclonal antibody, immunoassay, etc.) and their prospective applications for infectious disease testing; plus listings of companies developing or marketing infectious disease diagnostic products (by test).
  •     Strategic analyses of top suppliers and emerging market entrants.

More comprehensive and new research reports by the publisher can be found at VPG page.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld
2. Worldwide Chic Ladies Can Buy Cheap Evening Dresses at
3. Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld
4. Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week
5. As World Cup Comes to an End, Injuries are Star of the Show
6. World interest in research work on the benefits of the Okra plant
7. DARPA selects Lawrence Livermore to develop worlds first neural device to restore memory
8. Cancer Research UKs new funding scheme to nurture future world-leading scientists
9. Blind lead the way in brave new world of tactile technology
10. 2014 World Stem Cell Summit presented by GPI, Mary Ann Liebert, Inc, and GEN
11. Quest for education creating graying ghost towns at top of the world
Post Your Comments:
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: